Skip to main content

Table 2 Association between sociodemographic, clinical, and hematologic variables of patients with pediatric ALL

From: Clinical characteristics and outcomes of patients with pediatric acute lymphoblastic leukemia after induction of chemotherapy: a pilot descriptive correlational study from Palestine

    Hemoglobin (g/dL) Platelet count Initial WBC count Absolute neutrophil count
Variable n % Median IQR Mean rank P value Median IQR Mean rank P value Median IQR Mean rank P value Median IQR Mean rank P value
Age (years)
 < 10 26 37.7 7.8 2.8 26.6 0.007 57000 93000 30.2 0.119 7700 26400 37.3 0.454 1790 3830 35.0 0.289
 ≥ 10 43 62.3 9.1 2.5 40.1 118500 167000 37.9 4600 11028 33.6 1410 1640 30.0
Gender
 Male 42 60.9 8.5 3.0 38.3 0.088 87000 162500 36.1 0.563 7100 18700 38.4 0.077 1600 2700 34.9 0.137
 Female 27 39.1 9.0 3.6 29.9 67000 171000 33.3 5000 7550 29.7 940 1870 27.9
Presence of abdominal pain
 Yes 22 31.9 9.0 3.5 34.2 0.822 88500 179000 35.6 0.867 5100 10670 36.4 0.690 1310 2450 31.9 0.982
 No 47 68.1 8.8 3.0 35.4 64000 167000 34.7 7100 16700 34.3 1500 2390 32.0
Presence of fever
 Yes 37 53.6 9.0 2.6 37.8 0.217 78000 155250 34.7 0.909 4900 17178 34.8 0.942 1300 2595 34.8 0.188
 No 32 46.4 8.5 2.5 31.8 64000 180500 35.3 7700 13950 35.2 1500 1759 28.7
Presence of bone pain
 Yes 30 43.5 9.1 2.9 34.8 0.928 59000 123000 33.2 0.506 5300 13100 33.4 0.553 1600 1800 34.4 0.341
 No 39 56.5 8.7 2.2 35.2 88500 185500 36.4 5650 16725 36.3 975 3177 30.0
Pallor
 Yes 50 72.5 8.5 2.8 32.6 0.111 84000 157000 35.9 0.537 5300 13970 34.0 0.515 1420 2200 31.9 0.950
 No 19 27.5 9.4 3.5 41.2 65500 211800 32.6 7300 19750 37.6 1450 2335 32.3
Presence of anorexia
 Yes 9 13.0 8.3 2.6 30.3 0.449 121000 168000 37.3 0.708 17700 32350 40.8 0.354 1500 3630 38.2 0.276
 No 60 87.0 9.0 2.5 35.7 71000 158000 34.7 5000 12643 34.1   1410 2348 31.0
Presence of hepatomegaly
 Yes 34 49.3 9.0 1.6 36.1 0.644 50000 144500 31.5 0.151 5000 15750 36.6 0.513 1400 3030 32.8 0.735
 No 35 50.7 8.3 3.8 33.9 118500 173000 38.4 6350 14350 33.4 1460 2075 31.3
Presence of splenomegaly
 Yes 34 49.3 9.0 1.7 37.1 0.381 49500 145850 28.8 0.012 7200 24300 38.0 0.216 1600 4295 35.3 0.180
 No 35 50.7 7.8 3.0 32.9 122000 169000 41.0 5200 9250 32.1 1060 1615 29.0
Presence of bleeding
 Yes 15 21.7 8.0 4.5 30.6 0.333 34000 66050 22.9 0.008 9600 12335 39.1 0.367 1640 1170 35.2 0.481
 No 54 78.3 8.9 2.2 36.2 103000 171000 38.4 4900 15300 33.9 1300 2725 31.2
Immunophenotype                   
 B-cell ALL 55 79.7 8.4 2.5 30.0 ≤0.001 72000 156000 34.3 0.546 5000 10950 30.6 ≤0.001 1050 1730 29.4 0.011
 T-cell ALL 14 20.3 11.2 2.8 54.6 97500 264600 37.9 22100 35550 52.3 2670 4595 45.6
Relapse
 Yes 5 7.2 7.8000 1.35 31.8 0.711 60500 166750 38.2 0.711 1290 12353 24.7 0.233 290 3348 19.8 0.167
 No 64 92.8 9.0000 2.80 35.3 84000 166000 34.8 5600 14500 35.8 1500 2150 32.8